Investigating associations between non-adherence to guideline-recommended treatment of pediatric seizures and adverse outcomes: a Canadian feasibility study

Meaghan Moreau,Helen Coo,Niveditha Pattathil,Vinay Kukreti,Steven C. Brooks,Anupam Sehgal

DOI: https://doi.org/10.1016/j.pediatrneurol.2024.04.021

IF: 4.21

2024-04-27

Pediatric Neurology

Abstract:Background Emerging evidence suggests that non-adherence to treatment guidelines for seizures may affect patient outcomes. We examined the feasibility of conducting a larger investigation to test this hypothesis in the pediatric population. Methods We retrospectively reviewed charts of patients ≤18 years of age who presented with seizure to the emergency departments of two Ontario hospitals in 2019–2021. Patients were grouped by seizure duration (<5 [n=37], ≥5 minutes [n=41]). We examined non-adherence to guideline-recommended treatment, adverse outcomes (hospitalization, length of stay, respiratory complications), and missing values for key variables. Results Thirty-four of 78 patients (44%) did not receive guideline-recommended treatment. Non-adherence was similar in the two groups (<5 minutes: 46%; ≥5 minutes: 42%). The most common deviations included administering an antiseizure medication (ASM) for seizures lasting 10 minutes) between the first and second ASM doses (50%); and using a benzodiazepine for the third dose (45%). Hospitalizations were common in both seizure duration groups (∼90%) whereas respiratory complications were relatively rare (particularly in the <5-minute group, where they affected only 2 patients [5.4%]). Time of seizure onset was missing in 51% of charts and none contained the time of first contact with emergency services when patients were transported by ambulance. Interpretation We found evidence of substantial non-adherence to guideline-recommended treatment of pediatric seizures. Medical records do not contain sufficient information to comprehensively investigate this issue. A multi-centre prospective study is the most feasible option to examine the association between non-adherence to guideline-recommended treatment and patient outcomes.

pediatrics,clinical neurology